↓ Skip to main content

Cochrane Database of Systematic Reviews

Anticonvulsants for fibromyalgia

Overview of attention for article published in this source, October 2013
Altmetric Badge


100 Dimensions

Readers on

153 Mendeley
Anticonvulsants for fibromyalgia
Published by
John Wiley & Sons, Ltd, October 2013
DOI 10.1002/14651858.cd010782
Pubmed ID

Üçeyler, Nurcan, Sommer, Claudia, Walitt, Brian, Häuser, Winfried


Fibromyalgia (FM) is a clinically well-defined chronic condition of unknown aetiology characterised by chronic widespread pain that often co-exists with sleep problems and fatigue. People often report high disability levels and poor health-related quality of life (HRQoL). Drug therapy focuses on reducing key symptoms and disability, and improving HRQoL. Anticonvulsants (antiepileptic drugs) are drugs frequently used for the treatment of chronic pain syndromes.

X Demographics

X Demographics

The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 153 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Unknown 152 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 15%
Student > Bachelor 20 13%
Student > Doctoral Student 15 10%
Student > Postgraduate 15 10%
Student > Ph. D. Student 14 9%
Other 32 21%
Unknown 34 22%
Readers by discipline Count As %
Medicine and Dentistry 57 37%
Nursing and Health Professions 16 10%
Psychology 11 7%
Pharmacology, Toxicology and Pharmaceutical Science 9 6%
Neuroscience 5 3%
Other 18 12%
Unknown 37 24%